Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Director Shareholding

15 Oct 2012 14:01

Director Shareholding

15 October 2012 - London, UK - Verona Pharma plc (AIM: VRP.L) (the "Company") has received notification that on 12 October 2012, Jan-Anders Karlsson, CEO and a director of the Company, acquired an interest in 150,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 4.5 pence per share.

Following the acquisition, Dr. Karlsson will have an interest in the Company of 150,000 Ordinary Shares, representing 0.05% of the Company's issued ordinary share capital.

-Ends-

For more information please contact:

Verona Pharma plc Tel: 020 7863 3300 Jan-Anders Karlsson, CEO info@veronapharma.com WH Ireland Group Plc Tel: 020 7220 1650 Chris Fielding Chris.fielding@WH-Ireland.Co.UK

XLON
Date   Source Headline
11th May 20094:21 pmPRNIssue of Equity
31st Mar 20094:11 pmPRNNotice of Interest in the Company
25th Mar 20097:00 amPRN2008 Preliminary Unaudited Results
28th Jan 20097:00 amPRNApproval to Start Clinical Trials
9th Jan 20092:13 pmRNSHolding(s) in Company
11th Nov 20084:47 pmRNSHolding(s) in Company
23rd Sep 20087:00 amPRNHalf-yearly Report
9th Sep 20087:00 amPRNUpdate on Clinical Trials
31st Jul 20087:00 amPRNTotal Voting Rights
7th Jul 20085:10 pmPRNIssue of Equity
23rd May 20084:36 pmRNSResult of AGM
19th May 20087:00 amPRNPlanned asthma and hay fever drug passes crucial tests
14th May 20087:00 amPRNIssue of Equity
30th Apr 20089:18 amRNSIssue of Equity
2nd Apr 20087:00 amPRN2007 Preliminary Financial Results
19th Mar 20081:26 pmPRNChange of Registered Office
26th Feb 20087:00 amPRNProgress Update
31st Jan 20087:00 amPRNTotal Voting Rights Update
17th Jan 20081:27 pmPRNNotification of Interest
11th Jan 20087:00 amPRNNotification of Interest
9th Jan 200812:44 pmPRNNotification of Interest
7th Jan 200812:06 pmPRNResult of General Meeting & Directors' Holdings
31st Dec 20077:00 amRNSTotal Voting Rights
31st Dec 20077:00 amPRNTotal Voting Rights in Company
17th Dec 20077:00 amPRNProposed Placing and Notice of General Meeting
10th Dec 200712:07 pmPRNIssue of Equity
13th Nov 20077:00 amPRNVerona Pharma seeks drug treatment for coughing
6th Nov 20072:47 pmPRNVerona Pharma Progresses Anti-Asthma Drug Studies
4th Oct 20077:00 amPRNVerona Pharma launches regulatory studies for RPL554
10th Sep 20074:21 pmPRNInterim Report For The Six Months Ended 30 June 2007
16th Aug 20075:07 pmPRNHolding(s) in Company
1st Aug 20071:44 pmPRNNotification of Website Address
2nd Jul 20073:23 pmPRNDirector Shareholding
25th Jun 200711:09 amPRNDirector Shareholding
29th May 200712:11 pmPRNCommencement of RPL554 Preclinical Studies
9th May 200710:43 amRNSApptmnt of Nomad & Broker
26th Apr 20077:01 amRNSFinal Results
20th Mar 20077:00 amPRNAgreement with HepMim Biosciences
5th Feb 20075:58 pmPRNDirector/PDMR Shareholding
22nd Jan 20077:00 amPRNRPL554 Update
15th Dec 200612:43 pmPRNTotal Voting Rights
15th Dec 20067:00 amPRNUPDATE ON NAIPS PROGRAMME
27th Nov 20067:00 amPRNRPL554 Drug development project
2nd Oct 20061:09 pmRNSHolding(s) in Company
2nd Oct 200611:23 amRNSCompany Secretary Appointment
29th Sep 20069:28 amRNSInterim Results
19th Sep 20067:00 amRNSReadmission and name change
18th Sep 20068:57 amRNSResult of EGM
15th Sep 200611:23 amRNSSch 1 Update - ISIS Resources
1st Sep 200610:10 amRNSSch 1 - ISIS Resources PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.